LeMaitre Vascular Inc（LMAT）のニュースとイベント

$85.330

+1.690 (+1.98%)終値時点

LMAT のニュース

9.510-12Newsfilter

LeMaitre Vascular Schedules Q3 2026 Earnings Release and Conference Call

1.008-27Newsfilter

LeMaitre Vascular to Participate in Upcoming Investor Conferences

1.008-06Globenewswire

LeMaitre Vascular to Host Investor Meetings at Needham Conference

1.008-06Newsfilter

LeMaitre Vascular to Hold Investor Meetings at Needham Conference

9.508-05seekingalpha

LeMaitre Vascular Q2 2026 Earnings Call Insights

9.507-14Newsfilter

LeMaitre Vascular to Release Q2 2026 Financial Results on August 4

6.505-23Yahoo Finance

LeMaitre Stock Performance Analysis and Outlook

1.005-20Newsfilter

LeMaitre Vascular to Participate in Investor Conferences

9.505-06seekingalpha

LeMaitre Vascular Reports Strong Q1 2026 Earnings Growth and Strategic Outlook

9.505-05Yahoo Finance

LeMaitre Vascular Earnings Preview

ニュースをもっと見る

LMAT のイベント

8/5 12:30

LeMaitre Shares Drop 21.2% to $83.36

LeMaitre is down -21.2%, or -$22.42 to $83.36.

8/5 10:30

LeMaitre Shares Drop 19.6% to $85.00

LeMaitre is down -19.6%, or -$20.78 to $85.00.

8/4 16:30

2026 Revenue Forecast $274.3M-$278.3M

Sees 2026 revenue $274.3M-$278.3M, consensus $279.97M.

8/4 16:30

Company Reports Q2 Revenue of $70.4M, Below Consensus

Reports Q2 revenue $70.4M, consensus $71.47M. The company said, ""Our focus on the Artegraft international launch paid off in Q2. The product is now approved in 56 countries, accounting for 21% of sales. So our largest product is now our fastest-growing product. To underpin the Artegraft launch and pave the way for RFA, we continue to build our sales force, go direct in new countries and we're now undertaking six international warehouse expansions. $376m of cash provides strategic optionality."

8/4 16:30

Company Sees Q3 Revenue of $66.3M-$68.3M

Sees Q3 revenue $66.3M-$68.3M, consensus $69.19M.

イベントをもっと見る

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。